You are viewing the site in preview mode
Skip to main content
Bacterial isolates
Total no
Antimicrobial susceptibility N (%)
AMP
CHL
CRO
CIP
SXT
CN
AMC
ERY
S. aureus
31
S
9 (29)
18 (58)
22 (71)
23 (74.2)
8 (25.8)
20 (64.5)
20 (64.5)
19 (61.3)
I
3 (9.7)
3 (9.7)
3 (9.7)
2 (6.5)
3 (9.7)
4 (12.9)
3 (9.7)
2 (6.5)
R
19 (61.3)
10 (32.3)
6 (19.3)
6 (19.3)
20 (64.5)
7 (22.6)
8 (25.8)
10 (32.2)
CoNS
127
S
50 (39.4)
86 (67.7)
103 (81.1)
101 (79.5)
40 (31.5)
102 (80.3)
82 (64.5)
78 (61.4)
I
10 (7.9)
10 (7.9)
9 (7.1)
4 (3.2)
7 (5.5)
1 (0.8)
11 (8.7)
10 (7.9)
R
67 (52.7)
31 (24.4)
15 (11.8)
22 (17.3)
80 (63)
24 (18.9)
34 (26.8)
39 (30.7)
Streptococci spp.
13
S
7 (53.8)
9 (69.2)
12 (92.3)
8 (61.5)
11 (84.6)
1 (7.7)
7 (53.8)
7 (53.8)
I
–
–
1(7.7)
–
–
1(7.7)
–
–
R
6 (46.2)
4 (30.8)
–
5 (38.5)
2 (15.4)
11 (84.6)
6 (46.2)
6 (46.2)
S
3 (21.4)
5 (35.6)
9 (64.3)
12 (85.7)
6 (42.9)
14 (100)
8 (57.1)
9 (64.3)
E.coli
14
I
–
1 (14.3)
1 (7.1)
–
–
–
1 (7.1)
1 (7.1)
R
11 (78.6)
8 (57.1)
4 (28.6)
2 (14.3)
8 (57.1)
–
5 (35.8)
4 (28.6)
S
9 (60)
10 (66.7)
15 (100)
15 (100)
4 (26.7)
5 (35.7)
9 (60)
8 (53.3)
Klebsiella spp.
15
I
–
–
–
–
1 (6.7)
6 (42.9)
2 (13.3)
–
R
6 (40)
5 (33.3)
–
–
10 (66.6)
4 (21.4)
4 (33.3)
7 (46.7)
Pseudomonas spp.
8
S
–
4 (50)
5 (62.5)
3 (37.5)
–
7 (87.5)
–
–
R
8 (100)
4 (50)
3 (37.5)
5 (62.5)
8 (100)
1 (12.5)
8 (100)
8 (100)
Citrobacter spp.
8
S
2 (25)
3 (37.5)
8 (100)
5 (62.5)
3 (37.5)
8 (100)
3 (37.5)
2 (25)
R
6 (75)
5 (62.5)
–
3 (37.5)
5 (62.5)
–
5 (62.5)
6 (75)
S
80 (37)
135 (62.5)
174 (80.6)
167 (77.3)
72 (33.3)
157 (72.7)
129 (59.7)
123 (57)
Total
I
13 (6)
14 (6.5)
14 (6.5)
6 (2.8)
11 (5.1)
12 (5.6)
17 (7.9)
13 (6)
R
123 (56.9)
67 (31.02
28 (13)
43 (19.9)
133 (61.6)
47 (21.8)
70 (32.4)
80 (37)
AMP ampicillin, CHL chloramphenicol, CRO ceftriaxone, CIP ciprofloxacin, CN gentamicin, SXT trimethoprim-sulfamethoxazole, AMC amoxicillin-clavulanate, ERY erythromycin, CoNS coagulase-negative staphylococci species
